Injective INJ
Current Price
$3.44 +3.77%
$0.1900 Daily Range (5.52%)
$3.31$3.50
$69.55M Daily Volume
896 BTC
Vol/MktCap: 20.26%
Market Performance
0.21% Relative BTC Volume
The total volume of Injective is $69.55M over the past 24 hours, compared to $33.49B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.44 +0.04%
13 SMA $3.43 +0.32%
21 SMA $3.41 +0.82%
55 SMA $3.35 +2.72%
144 SMA $3.30 +4.29%
Price Performance
+0.18% 1 Hour Change
$3.44 from $3.43
+0.35% 7 Day Change
$0.0121 from $3.43
+12.91% 14 Day Change
$0.4442 from $3.00
+11.40% 30 Day Change
$0.3920 from $3.05
All Time High
March 14, 2024
$52.62 -93.49%
-$49.20 vs. now
24H Change
13.19M USD +3.99%
170 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
4.99 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
20.43M INJ
traded over past 24 hours
20.43% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.43, experiencing a 24-hour change of 4.26%, indicating a bullish short-term sentiment. The daily range has been relatively stable, with a high of $3.50 and a low of $3.28, suggesting a healthy trading environment with low volatility.
Volume stands at approximately 69.54 million, translating to a 20.31% ratio of volume to market cap, which reflects robust trading activity relative to its market capitalization. This volume is supportive of the recent price increase, indicating strong market interest and potential liquidity for traders.
The moving averages indicate a positive trend; the 8-period SMA is at $3.43 with a slight increase of 0.09%, while the 55 SMA shows a more significant rise of 2.69%. The upward momentum is further confirmed by the 14-day price change of 15.03%, suggesting that INJ is in a solid bullish trend over the short to medium term.
The 1-hour RSI is at 56, indicating that INJ is nearing overbought conditions, while the 7-day RSI at 53 suggests it remains in a neutral zone. This positioning indicates potential for further upward movement, but traders should monitor for signs of overextension.
Given the proximity to its all-time high of $52.62 reached earlier this year, the current price of $3.43 represents a significant discount, offering potential for substantial returns if upward momentum continues. The strong technical indicators, coupled with consistent volume and positive price trends, suggest that the market sentiment remains favorable.
Based on this analysis, a Buy rating is warranted. The combination of positive price movement, strong technical indicators, and a solid volume-to-market cap ratio supports a bullish outlook for Injective (INJ) in the near term.
Volume stands at approximately 69.54 million, translating to a 20.31% ratio of volume to market cap, which reflects robust trading activity relative to its market capitalization. This volume is supportive of the recent price increase, indicating strong market interest and potential liquidity for traders.
The moving averages indicate a positive trend; the 8-period SMA is at $3.43 with a slight increase of 0.09%, while the 55 SMA shows a more significant rise of 2.69%. The upward momentum is further confirmed by the 14-day price change of 15.03%, suggesting that INJ is in a solid bullish trend over the short to medium term.
The 1-hour RSI is at 56, indicating that INJ is nearing overbought conditions, while the 7-day RSI at 53 suggests it remains in a neutral zone. This positioning indicates potential for further upward movement, but traders should monitor for signs of overextension.
Given the proximity to its all-time high of $52.62 reached earlier this year, the current price of $3.43 represents a significant discount, offering potential for substantial returns if upward momentum continues. The strong technical indicators, coupled with consistent volume and positive price trends, suggest that the market sentiment remains favorable.
Based on this analysis, a Buy rating is warranted. The combination of positive price movement, strong technical indicators, and a solid volume-to-market cap ratio supports a bullish outlook for Injective (INJ) in the near term.
Updated 374 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
You May Also Like
In The News

Iran’s parliament speaker Ghalibaf skips Islamabad talks, casting doubt on progress
Ghalibaf's absence highlights potential internal discord in Iran, raising uncertainty about future diplomatic engagements with the US.

White House confirms Jerome Powell investigation ongoing, US-Iran relations progress
The ongoing investigation and US-Iran relations progress could significantly impact geopolitical stability and economic markets.

Lebanon confirms negotiations with Israel to prevent prolonged conflict
Diplomatic efforts between Lebanon and Israel could stabilize regional tensions, influencing broader Middle Eastern geopolitical dynamics.

White House press secretary Leavitt steps back for maternity leave
Leavitt's leave may shift market dynamics as communication roles transition, potentially impacting geopolitical and prediction market activities.